ARTICLE | Strategy
Shaman inverts its drug development model
November 14, 1994 8:00 AM UTC
Noteworthy
With its long-term capital security in mind, Shaman Pharmaceuticals Inc. has decided to focus on the pharmaceutical industry as its primary customer and will concentrate its development efforts in diseases best modeled by whole animal testing. ...